Last reviewed · How we verify

NCT01977612

Randomized Clinical Trial of Skin Closure With Staples Versus Suture

Completed Phase 2 Results posted Last updated 31 July 2017
What this trial tests

Phase 2 trial testing 4-0 monofilament suture in Wound Infection in 173 participants. Completed in 30 June 2016.

Timeline
15 May 2013
Primary endpoint
17 June 2016
30 June 2016

Quick facts

Lead sponsorWashington University School of Medicine
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment173
Start date15 May 2013
Primary completion17 June 2016
Estimated completion30 June 2016
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Washington University School of Medicine

Who can join

Adults 18 to 85, female only, with Wound Infection or Wound Complication. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Wound Disruption or Infection (Wound Complications) Occurring Within 4-8 Weeks of the Date of the Primary Surgery. Primary · 4-8 weeks post-surgery
GroupValue95% CI
Stainless Steel Staples28
4-0 Monofilament Sutures25
Incidence of Wound Disruption Secondary · 4-8 weeks post-surgery
GroupValue95% CI
Stainless Steel Staples21
4-0 Monofilament Sutures13
Incidence of Wound Infection Secondary · 4-8 weeks post-surgery

Purulent drainage, cellulitis, abscess, or a wound that requires drainage, debridement or antibiotics associated with a clinical diagnosis of infection.

GroupValue95% CI
Stainless Steel Staples1
4-0 Monofilament Sutures1
Operative Time Secondary · During surgery

Time from skin incision to the end of skin closure

GroupValue95% CI
Stainless Steel Staples32 – 4
4-0 Monofilament Sutures119 – 15
Cosmesis Score as Measured by the Stony Brook Scar Evaluation Score Secondary · 4-8 weeks post-operative

* Ranges from 0 (worst) to 5 (best) * Sum of width, height, color, hatch, and overall appearance where a better outcome has a value of 5 and a worse outcome has a value of 0

GroupValue95% CI
Stainless Steel Staples43 – 5
4-0 Monofilament Sutures54 – 5
Median Patient Satisfaction Score of Scar Appearance Secondary · 4-8 weeks post-operative

Patients will be asked to rate the general appearance, location and comfort of the scar. This was collected as a continuous variable. Patients were given a paper survey and asked to please draw a single slash across a provided line indicating how satisfied they were with the appearance of their scar. The beginning of the line was designated "very unsatisfied" or 0% and the end of the line was "very satisfied" or 100%.

GroupValue95% CI
Stainless Steel Staples6849 – 83
4-0 Monofilament Sutures7752 – 87

Sponsor's own description

Women with gynecologic cancers are often obese and have other risk factors for post-operative wound separation. Data from obstetrics and orthopedic surgery literature have shown a decreased risk of wound separation and complications when the skin is closed with suture as compared to staples. Skin closure with either staples or suture is considered standard of care. Traditionally, most wounds have been closed with staples given their ease of use and quick application. In this randomized study the investigators plan to evaluate and compare the complication rate associated with both standard closures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.
    Kuroki LM, Mullen MM, Massad LS, Wu N, et al · · 2017 · cited 18× · PMID 28594761 · DOI 10.1097/aog.0000000000002061

Verify or expand the search:

Other recruiting trials for Wound Infection

Currently open trials in the same condition.

Other Washington University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01977612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing